Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-15 Purchase |
2022-06-16 09:54 am |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer |
10,000 | $1.0219 | $10,219 | 67,000 (Direct) |
View |
| 2022-06-10 Purchase |
2022-06-14 4:16 pm |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer |
14,000 | $1.0558 | $14,781 | 57,000 (Direct) |
View |
| 2022-05-20 Purchase |
2022-05-24 4:03 pm |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer |
28,000 | $0.90054 | $25,215 | 43,000 (Direct) |
View |
| 2021-06-23 Sale(A) |
2022-02-04 5:35 pm |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
11,900 | $6.721 | $79,980 | 351,169 (Direct) |
View |
| 2021-06-23 Sale |
2021-06-25 12:10 pm |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
11,900 | $6.721 | $79,980 | 1,077,306 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-16 Option Award |
2023-03-20 1:39 pm |
N/A 2033-03-16 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Andrle Edward Director |
39,503 | $0 | 83,152 (Direct) |
View |
| 2023-02-03 Tax Withholding |
2023-02-07 4:44 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
6,054 | $1.47 | 35,696 (Direct) |
View |
| 2023-02-03 Tax Withholding |
2023-02-07 4:37 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
2,175 | $1.47 | 363,994 (Direct) |
View |
| 2023-02-03 Tax Withholding |
2023-02-07 4:18 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
53,750 | $1.47 | 460,858 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-02 4:22 pm |
N/A 2032-05-31 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | MATHIESEN JEFFREY S Director |
58,470 | $0 | 95,290 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-02 4:12 pm |
N/A 2032-05-31 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | BUCKMAN PAUL Director |
58,470 | $0 | 89,902 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-02 4:02 pm |
N/A 2032-05-31 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Andrle Edward Director |
58,470 | $0 | 72,879 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-04 6:37 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-04 6:26 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
250,000 | $0 | 514,608 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-04 6:17 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
41,750 | $0 | 41,750 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-04 5:44 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
15,000 | $0 | 366,169 (Direct) |
View |
| 2021-05-26 Option Award |
2021-10-07 4:03 pm |
N/A 2031-01-27 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
83,333 | $0 | 416,667 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 4:29 pm |
N/A 2031-06-02 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | MATHIESEN JEFFREY S Director |
9,274 | $0 | 41,493 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 4:18 pm |
N/A 2031-06-02 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | BUCKMAN PAUL Director |
9,274 | $0 | 36,106 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 4:06 pm |
N/A 2031-06-02 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Andrle Edward Director |
9,274 | $0 | 19,086 (Direct) |
View |
| 2021-04-26 Option Award |
2021-04-28 6:13 pm |
N/A 2031-04-26 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Haris Hijaz VP of Marketing |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 5:10 pm |
N/A 2031-01-27 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer |
140,000 | $0 | 140,000 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 4:59 pm |
N/A 2031-01-27 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
70,000 | $0 | 70,000 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 4:49 pm |
N/A 2031-01-27 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
Ownership |
2021-01-21 11:52 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | BESSER JAMES E FRANK MORGAN C. MANCHESTER MANAGEMENT CO LLC MANCHESTER MANAGEMENT PR LLC Manchester Explorer L.P. 10% Owner |
0 | $0 | 10,242,951 (Direct) |
View |
| 2021-01-01 Option Award |
2021-01-05 2:41 pm |
N/A 2031-01-01 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer |
180,000 | $0 | 180,000 (Direct) |
View |